🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
The purpose of this study is to investigate the safety and effectiveness of...
Status
Terminated
Location
Orange County Research Center
Start Date
2013-12
Trial ID
NCT02020616
Treatments Being Tested
This is a 28-week, multi-center, randomized, double-blind, placebo-controll...
Status
Terminated
Location
Diabeteszentrum Oldenburg
Start Date
2018-02-19
Trial ID
NCT03419624
Study D5553C00002 is a multicenter, randomized, double-blind, placebo-contr...
Status
Completed
Location
Research Site
Start Date
2014-09-06
Trial ID
NCT02229383
Treatments Being Tested
The aim of the study is to compare the efficacy and safety of two JY09 dose...
Status
Active Not Recruiting
Location
Peking University First Hospital
Start Date
2024-07-17
Trial ID
NCT06257966
Obesity is a medical condition which increases the risk of other diseases, ...
Status
Completed
Location
Dept of Medical Sciences, Clinical Diabetes and Metabolism, Uppsala University and Section for Diabetes and Endocrinology at the Uppsala University Hospital
Start Date
2014-12
Trial ID
NCT02313220
Treatments Being Tested
Among adult individuals with type 2 diabetes mellitus and at risk for heart...
Status
Completed
Location
Baylor Scott and White Research Institute- Baylor Heart and Vascular Hospital
Start Date
2015-11
Trial ID
NCT02251431
The study titled "Efficacy and Safety of Omarigliptin, A Weekly Dipeptidyl ...
Status
Unknown
Location
BIRDEM General Hospital
Start Date
2024-09
Trial ID
NCT06449235
A Randomized, Open-Label, Multicenter, Comparator-Controlled Study to Exami...
Status
Completed
Location
Research Site 182
Start Date
2006-04
Trial ID
NCT00308139
Treatments Being Tested
The purpose of this study is to determine the optimal dose or doses of HM11...
Status
Completed
Location
Hanmi pharmaceutical
Start Date
2014-01
Trial ID
NCT02057172
Treatments Being Tested
The purpose of this study is to evaluate the safety, tolerability and drug ...
Status
Completed
Location
CMax
Start Date
2024-12-20
Trial ID
NCT05670379
Treatments Being Tested